Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD

Neuropediatrics

Volumn 41, Issue 2, 2010, Pages 55-59

  Zhang, H ^a   Du, M ^a   Zhuang, S ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

ADHD; attention deficit hyperactivity disorder; height; methylphenidate; weight

Indexed keywords

METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; BODY HEIGHT; BODY WEIGHT; CHILD; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; PRESCHOOL CHILD; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT DURATION;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METHYLPHENIDATE; QUESTIONNAIRES; REGRESSION ANALYSIS;

EID: 77956252632     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0030-1261893     Document Type: Article

References (19)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edn. (DSM-IV) Washington American Psychiatric Association 1994 100-105
2. Greenhill LL, Halperin JM, Abikoff H. Stimulant medications. J Am Acad Child Adolesc Psychiatry 1999 38 503-512
3. Kilgore BS, Dickinson LC, Burnett CR, et al. Impaired growth in hyperkinetic children receiving pemoline. J Pediatr 1979 94 538-541
4. Klein RG. Clinical efficacy of methylphenidate in children and adolescents. Encephale 1993 19 89-93
5. Lisska MC, Rivkees SA. Daily methylphenidate use slows the growth of children: a community based study. J Pediatr Endocrinol Metab 2003 16 711-718
6. Mattes JA, Gittelman R. Growth of hyperactive children on maintenance regimen of methylphenidate. Arch Gen Psychiatry 1983 40 317-321
7. Poulton A, Cowell CT. Slowing of growth in height and weight on stimulants: a characteristic pattern. J Paediatr Child Health 2003 39 180-185
8. Ranke MB, Blum WF, Bierich JR. Clinical relevance of serum measurements of insulin-like growth factors and somatomedin binding proteins. Acta Paediatr Scand Suppl 1988 347 114-126
9. Rosenfield RL. Somatic growth and maturation. In: DeGroot LJ Besser GM Cahill GF Jr, eds, Endocrinology. Philadelphia WB Saunders 1989 2242-2282
10. Safer D, Allen R, Barr E. Depression of growth in hyperactive children on stimulant drugs. N Engl J Med 1972 287 217-220
11. Safer D, Allen R. Factors influencing the suppressant effects of 2 stimulant drugs on the growth of hyperactive children. J Pediatr 1973 51 660-667
12. Safer D, Allen R, Barr E. Growth rebound after termination of stimulant drugs. J Pediatr 1975 86 113-116
13. Schertz M, Adesman AR, Alfieri NE, et al. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication. Pediatrics 1996 98 763-769
14. Sirois PA, Montepiedra G, Kapetanovic S, et al. Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and adolescents with HIV. J Dev Behav Pediatr 2009 30 403-412
15. Spencer T, Biederman J, Wright V, et al. Growth deficits in children treated with desipramine: a controlled study. J Am Acad Child Adolesc Psychiatry 1992 31 235-243
16. Spencer T, Biederman J, Harding M, et al. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry 1996 35 1460-1469
17. Spencer T, Biederman J, Wilens T. Growth deficits in children with attention deficit hyperactivity disorder. Pediatrics 1998 102 501-506
18. Yamei H, Zaifang J, et al. Shi Yong Er Ke Xue. 7th edn. Beijing RenMinWeiSheng Press 2002 23-26, 37
19. Zametkin AJ, Rapoport JL. Noradrenergic hypothesis of attention deficit disorder with hyperactivity; a critical review. In: Meltzer HY Psychopharmacology: The Third Generation of Progress. New York Raven Press 1987 838-842